BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 28213088)

  • 1. Personalized medicine: Genetic risk prediction of drug response.
    Zhang G; Nebert DW
    Pharmacol Ther; 2017 Jul; 175():75-90. PubMed ID: 28213088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Variation among Pharmacogenes in the Sardinian Population.
    Idda ML; Zoledziewska M; Urru SAM; McInnes G; Bilotta A; Nuvoli V; Lodde V; OrrĂ¹ S; Schlessinger D; Cucca F; Floris M
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The medical and economic roles of pipeline pharmacogenetics: Alzheimer's disease as a model of efficacy and HLA-B(*)5701 as a model of safety.
    Roses AD
    Neuropsychopharmacology; 2009 Jan; 34(1):6-17. PubMed ID: 18923406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics polygenic risk score for drug response prediction using PRS-PGx methods.
    Zhai S; Zhang H; Mehrotra DV; Shen J
    Nat Commun; 2022 Sep; 13(1):5278. PubMed ID: 36075892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics - a minor rather than major force in clinical medicine.
    Polasek TM
    Expert Rev Clin Pharmacol; 2024 Mar; 17(3):203-212. PubMed ID: 38307498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying polygenic risk score methods to pharmacogenomics GWAS: challenges and opportunities.
    Zhai S; Mehrotra DV; Shen J
    Brief Bioinform; 2023 Nov; 25(1):. PubMed ID: 38152980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population structure and pharmacogenomic risk stratification in the United States.
    Nagar SD; Conley AB; Jordan IK
    BMC Biol; 2020 Oct; 18(1):140. PubMed ID: 33050895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Narrative Review on Pharmacogenomics in Psychiatry: Scientific Definitions, Principles, and Practical Resources.
    Palumbo S; Mariotti V; Pellegrini S
    J Clin Psychopharmacol; 2024 Jan-Feb 01; 44(1):49-56. PubMed ID: 38100778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mendelian randomization in pharmacogenomics: The unforeseen potentials.
    Khasawneh LQ; Al-Mahayri ZN; Ali BR
    Biomed Pharmacother; 2022 Jun; 150():112952. PubMed ID: 35429744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized Medicine: Pharmacogenomics and Drug Development.
    Mirsadeghi S; Larijani B
    Acta Med Iran; 2017 Mar; 55(3):150-165. PubMed ID: 28282716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A semi-supervised approach to extract pharmacogenomics-specific drug-gene pairs from biomedical literature for personalized medicine.
    Xu R; Wang Q
    J Biomed Inform; 2013 Aug; 46(4):585-93. PubMed ID: 23570835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Investigation of the Knowledge Overlap between Pharmacogenomics and Disease Genetics.
    Li B; Whirl-Carrillo M; Wright MW; Babb L; Rehm HL; Klein TE
    Pac Symp Biocomput; 2022; 27():385-396. PubMed ID: 34890165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions.
    Cacabelos R; Naidoo V; Corzo L; Cacabelos N; Carril JC
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimising Adverse Drug Reactions and Verifying Economic Legitimacy-Pharmacogenomics Implementation in Children (MARVEL- PIC): protocol for a national randomised controlled trial of pharmacogenomics implementation.
    Conyers R; Halman A; Moore C; Stenta T; Felmingham B; Collier L; Khatri D; Spelman T; Williams E; Dyas R; Kotecha RS; Jessop S; Mateos MK; Swen J; Elliott DA
    BMJ Open; 2024 May; 14(5):e085115. PubMed ID: 38760050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Challenge in genome-wide association study for establishment of personalized medicine: focusing on the pharmacogenomics of warfarin and carbamazepine].
    Mushiroda T
    Rinsho Byori; 2013 May; 61(5):422-7. PubMed ID: 23947182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving Pain Management with Pharmacogenomics: A General Introduction.
    Schuh MJ; Randles H; Crosby S
    J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):114-119. PubMed ID: 32186418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forging the path to precision medicine in Qatar: a public health perspective on pharmacogenomics initiatives.
    Bastaki K; Velayutham D; Irfan A; Adnan M; Mohammed S; Mbarek H; Qoronfleh MW; Jithesh PV
    Front Public Health; 2024; 12():1364221. PubMed ID: 38550311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomic testing in paediatrics: Clinical implementation strategies.
    Barker CIS; Groeneweg G; Maitland-van der Zee AH; Rieder MJ; Hawcutt DB; Hubbard TJ; Swen JJ; Carleton BC
    Br J Clin Pharmacol; 2022 Oct; 88(10):4297-4310. PubMed ID: 34907575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
    Ji Y; Si Y; McMillin GA; Lyon E
    Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human loci involved in drug biotransformation: worldwide genetic variation, population structure, and pharmacogenetic implications.
    Maisano Delser P; Fuselli S
    Hum Genet; 2013 May; 132(5):563-77. PubMed ID: 23354977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.